Global Genotyping Assay Market: Overview
The global genotype assay market is expected to increase remarkably in the years to come due to the rise in occurrences of diseases that are genetically acquired all over the world. The measurement of genetic difference of a single nucleotide polymorphisms or SNPs across other members of a particular species is known as genotyping.
There are different variations to the global genotyping assay market based on product and service, technology, application, and end-users. On the basis of product and services, the global market for genotyping assay is classified into reagents and kits, genotyping services, instruments, and bioinformatics. The instruments segment is further categorized into sequencers and amplifiers, and analyzers while the bioinformatics segment is further grouped into services and software. Among these, the reagents and kits segment holds a dominant share in the market as per the 2017 records.
With respect to technology, the global genotyping assay market is further categorized into microarrays, polymerase chain reaction, sequencing, capillary electrophoresis, and matrix-assisted laser desorption or ionization-time of flight mass spectrometry. On the basis of application, the market for genotyping assay is further labelled as pharmacogenomics, personalized medicine and diagnostics, animal genetics, and agricultural biotechnology. As per end user, the market is further categorized into biopharmaceutical and pharmaceutical companies, research and diagnostic laboratories, and academic institutes.
The report presented above is a complete evaluation of the global genotyping assay market with major focus on market dynamics. It also includes the market drivers, restraints, and trends, and opportunities. The above presented report also offers geographical and other segmentation of the market.
Global Genotyping Assay Market: Trends and Opportunitie
The global genotyping assay market is propelled by a number of factors. One among them is the increase in the number of genetic diseases all around the world. Following that is the general awareness regarding personalized medicine all around the world especially in the developed regions of the world.
Another important factor anticipated to boost the growth of the global genotyping assay market is the decrease in the cost of DNA sequencing along with other technological advancements. Besides, surge in the drug development and increasing importance and awareness of drug development is also fueling the overall market.
Global Genotyping Assay Market: Regional Analysis
The global market for genotyping assay can be segmented geographically into the regions of North America, Latin America, Middle East and Africa, Europe, and Asia Pacific. Among these, the North American region is expected to dominate the overall market due to the rising incidence of genetic diseases and immediate measures that are taken accordingly especially in the developed regions of Canada and the U.S. On the other hand, Europe is also seen to be growing in terms of improved healthcare and medical facilities and hence, the market in Europe and Asia Pacific is expected to grow during the forecast period on account of developing medical infrastructure in countries of UK, France and Germany in the European region and India, China, and Japan of the Asia Pacific region.
Global Genotyping Assay Market: Companies Mentioned
Prominent players of the global genotyping assay market are Roche Diagnostics Limited, Fluidigm Corporation, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., and Eurofins Scientific. The report studies in detail various strategies adopted by these companies and gauges the impact of the same on the overall market. It also conducts analyses to study strengths and weaknesses of the companies profiled.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.